Sectors
Health, Marketplace, Recruitment, Talent Management
Headquarters
Quincy, Massachusetts, USA
CEO
David Coppins
IntelyCare shares, as of April 21, 2025, are valued at a price per share implying an approximate +41.83% relative to the most recent significant secondary market activity in November 2023, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine IntelyCare's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for IntelyCare.
Register today to view the full report, with more in-depth details and analytics
Latest funding round
XXXXX
XX-XX-XXXX
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX
Business Partnerships
Targeted Impact
Who Will Benefit?
What Comes Next?
No items found.
.png)
IntelyCare shares, as of April 21, 2025, are valued at a price per share implying an approximate +41.83% relative to the most recent significant secondary market activity in November 2023, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine IntelyCare's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for IntelyCare.
IntelyCare's mutual fund disclosures indicate a three-month moving average fund price per share of $5.85 as of December 30, 2024, according to PM Insights' market data.
No items found.
No items found.
Ready to see it in action?
Schedule a demo with one of our experts
